Abbott Laboratories (NYSE:ABT) is engaged in discovery, development, manufacture, and sale of diversified line of healthcare products. Abbott Laboratories achieved its new price of $57.20 where it was opened at $57.15 down -0.43 points or -0.75% by closing at $56.61. ABT transacted shares during the day were over 8.10 million shares however it has an average volume of 7.27 million shares.

Abbott Laboratories (NYSE:ABT) is engaged in discovery, development, manufacture, and sale of diversified line of healthcare products. Abbott Laboratories achieved its new 52 week high price of $56.74 where it was opened at $56.33 up 0.41 points or 0.73% by closing at $56.70.

Abbott Laboratories (NYSE:ABT) is engaged in discovery, development, manufacture, and sale of diversified line of healthcare products. It has four segments: Pharmaceutical Products, which include a line of adult and pediatric pharmaceuticals manufactured, which include a line of diagnostic systems and tests manufactured, and vessel closure devices for the treatment of vascular disease.

Crown Equity Holdings Inc. (CRWE)